Jennifer Mosebach

Learn More
PET/MRI represents a promising hybrid imaging modality with several potential clinical applications. Although PET/MRI seems highly attractive in the diagnostic approach of multiple myeloma (MM), its role has not yet been evaluated. The aims of this prospective study are to evaluate the feasibility of (18)F-FDG PET/MRI in detection of MM lesions, and to(More)
Aim of this prospective study was to assess the sensitivity of positron emission tomography (PET) and diffusion-weighted imaging (DWI) in detecting multiple myeloma (MM) lesions, using the well-established morphologic modalities magnetic resonance imaging (MRI) and computed tomography (CT) as the standard of reference (RS). The study included 24 MM patients(More)
Aim Comparison of the sensitivities in lesion detection of 18 F-FDG-positron emission tomography (PET) and diffusion weighted imaging (DWI) in multiple myeloma patients. Methods 24 primary and pre-treated patients diagnosed with multiple myeloma according to the International Myeloma Working Group criteria were examined by 18 F-FDG PET/CT and whole-body MRI(More)
Aim To compare the detection rates of different imaging modalities for nodular bone marrow (BM) infiltrates and osteolyses in patients with multiple myeloma (MM). Methods 55 Patients diagnosed according to the International Myeloma Working Group criteria (2003) were referred to consecutive imaging diagnostics including 18F-FDG PET/CT, T1-weighted and(More)
Die diffusionsgewichtete Bildgebung („diffusion-weighted imaging“, DWI), ein Verfahren aus der Magnetresonanztomographie (MRT), wurde in der klinischen Routine primär für die Detektion von Schlaganfällen etabliert. Der Einsatz dieser Methode hat in den letzten 15 Jahren auch für die onkologische Diagnostik stark zugenommen, da Tumoren und Metastasen(More)
  • 1